Mosby's 2014 Nursing Drug Reference (433 page)

BOOK: Mosby's 2014 Nursing Drug Reference
8.67Mb size Format: txt, pdf, ePub
lorcaserin

(lor-ca-ser′in)

Belviq

Func. class.:
Weight-control agent (anorexiant)

Chem. class.:
Serotonin 2C (5-HT
2C
) receptor agonist

ACTION:

Decreases food consumption and decreases hunger by selectively activating 5-HT
2C
receptors

USES:

Obesity management

CONTRAINDICATIONS:

Pregnancy (X), breastfeeding, hypersensitivity, severe renal impairment

Precautions:
Children, other organic causes of obesity, anemia, AV block, bradycardia, bundle branch block, depression, dialysis, liver/kidney disease, multiple myeloma, neutropenia, suicidal ideation, Peyronie’s disease, pulmonary hypertension, sick sinus syndrome

DOSAGE AND ROUTES
Calculator
Adult:

• 
PO
10 mg bid; do not exceed recommended dosage

Available forms:
Tabs, film-coated 10 mg

Administer:

• 
For obesity if patient is on weight reduction program that includes dietary changes, exercise

• 
May give without regard to food

SIDE EFFECTS

CNS:
Insomnia, depression, serotonin syndrome, anxiety,
suicidal ideation,
dizziness, headache, fatigue

CV:
Bradycardia, hypertension

GI:
Diarrhea, constipation, nausea

HEMA:
Neutropenia, leukopenia, lymphopenia

INTEG:
Rash

MS:
Back pain

PHARMACOKINETICS

70% protein binding, half-life 11 hr

INTERACTIONS

Increase:
life-threatening serotonin syndrome or NMS—SSRIs, SNRIs, serotonin-receptor agonists, sibutramine, MAOIs, linezolid, tricyclic antidepressants, buPROPion, lithium, DOPamine antagonist, traMADol

Increase:
risk of hypoglycemia with sulfonylureas and insulin

Drug/Herb

Increase:
Serotonin syndrome—St. John’s wort

NURSING CONSIDERATIONS
Assess:

• 
Weight weekly; oral hypoglycemic dosage might need to be reduced in diabetic patients

• 
Monitor blood glucose, CBC with differential, Hct/Hgb, serum prolactin

 
Pregnancy (X): do not use in pregnancy

Suicidal ideation:

 
Use caution in psychiatric disorders with emotional lability; assess for depression, suicidal thoughts/behaviors

Evaluate:

• 
Therapeutic response: decrease in weight

Teach patient/family:

• 
To avoid hazardous activities until stabilized on medication

• 
To discuss unpleasant side effects

 
To notify prescriber if pregnancy is planned or suspected, pregnancy X

Canada only   Side effects:
italics
= common;
bold
= life-threatening   
Nurse Alert

lucinactant

(loo′sin-ak′tant)

Surfaxin

Func. class.:
Synthetic lung surfactant

USES:

Prevention of respiratory distress syndrome in premature neonates (RDS)

DOSAGE AND ROUTES
Calculator
Premature neonate

Intratracheal
5.8 ml/kg birth weight divided in 4 doses; give each dose with neonate in a different position; provide positive pressure ventilation when stable; dosage may be repeated 4 times in first 48 hr

Canada only   Side effects:
italics
= common;
bold
= life-threatening   
Nurse Alert

mirabegron

(mir′a-beg′ron)

Myrbetriq

Func. class.:
Bladder antispasmodic

Chem. class.:
β
3
Adrenergic receptor agonist

ACTION:

Relaxes smooth muscles in urinary tract

USES:

Overactive bladder (urinary frequency, urgency), urinary incontinence

CONTRAINDICATIONS:

Hypersensitivity

Precautions:
Pregnancy (C), breastfeeding, children, kidney/liver disease, bladder obstruction, dialysis, hypertension

DOSAGE AND ROUTES
Calculator

• Adult:
PO
25 mg/day, may increase to 50 mg/day if needed

Hepatic/renal dose

 
PO
Child–Pugh B or (CCr 15-29 ml/min, max 25 mg/day; Child–Pugh C or CCr <15 ml/min, not recommended

Available forms:
Tabs ext rel 25, 50 mg

Administer:

• 
Give whole; take with liquids; do not crush, chew, or break ext rel product; use without regard to meals

SIDE EFFECTS

CNS:
Fatigue, dizziness, headache

CV:
Hypertension

EENT:
Xerophthalmia, blurred vision

GI:
Nausea, vomiting, anorexia, abdominal pain, constipation, diarrhea, dyspepsia

GU:
Dysuria, urinary retention, frequency, UTI, bladder discomfort

INTEG:
Rash, pruritus

MISC:
Arthralgia, back pain

RESP:
Pharyngitis

SYST:
Stevens–Johnson syndrome

PHARMACOKINETICS

71% protein binding, excretion 25% unchanged in urine, terminal half-life 50 hr, peak 3.5 hr

INTERACTIONS

Increase:
Effect of digoxin, warfarin, desipramine, thioridazine, flecainide, propafenone

Increase:
risk of urinary retention with antimuscarinic agents (eg, atropine, scopolamine)

NURSING CONSIDERATIONS
Assess:

• 
Urinary patterns: distention, nocturia, frequency, urgency, incontinence

• 
LFTs at baseline, periodically

• 
Monitor B/P

Evaluate:

• 
Decreasing dysuria, frequency, nocturia, incontinence

Teach patient/family:

• 
To avoid hazardous activities; dizziness can occur

• 
Not to drink liquids before bedtime

• 
About the importance of bladder maintenance

Other books

Dark Dreamer by Fulton, Jennifer
Little Miss Lovesick by Kitty Bucholtz
The Sacrifice Stone by Elizabeth Harris
Stirring Attraction by Sara Jane Stone
Panic Attack by Jason Starr
The Savage City by T. J. English
Rescate peligroso by Jude Watson
Blackout by Jan Christensen
EXPECTING HIS CHILD by Leanne Banks
Silvertip's Roundup by Brand, Max